Literature DB >> 24890439

Mortality from chronic liver diseases in diabetes.

Giacomo Zoppini1, Ugo Fedeli2, Nicola Gennaro2, Mario Saugo2, Giovanni Targher1, Enzo Bonora1.   

Abstract

OBJECTIVES: Mortality from chronic liver diseases (CLDs) is increased in diabetes, but little is known about the etiology. The aim of this study was to assess mortality rates from CLD by etiology in known diabetic subjects living in the Veneto Region, Northern Italy.
METHODS: A total of 167,621 diabetic subjects, aged 30-89 years (54.6% men), were identified in the year 2007 and their vital status was assessed between 2008 and 2010. Standardized mortality ratios (SMR) with 95% confidence intervals (CIs) were computed with regional mortality rates as reference. The underlying cause of death and all comordidities reported on the certificate were scrutinized in order to identify CLD deaths and their main etiologies. The latter were grouped into the following three categories: (i) virus-related, (ii) alcohol-related, and (iii) non-virus, non-alcohol-related (mainly represented by nonalcoholic fatty liver disease, NAFLD).
RESULTS: Analyses were based upon 473,374 person-years of follow-up and 17,134 deaths. We observed an increased risk of dying from CLD in diabetic subjects with an SMR of 2.47 (95% CI=2.19-2.78) in men and 2.70 (2.24-3.23) in women. SMRs were 2.17 (1.90-2.47), 2.25 (1.98-2.54), and 2.86 (2.65-3.08) for virus-related, alcohol-related, and non-virus, non-alcohol-related CLD, respectively.
CONCLUSIONS: Diabetic patients have a twofold to threefold higher risk of dying of CLD, mainly associated with a non-virus and non-alcohol-related etiology, which is largely attributable to NAFLD. An early diagnosis and treatment of NAFLD, if any, may have a beneficial clinical impact on the survival of diabetic patients.

Entities:  

Mesh:

Year:  2014        PMID: 24890439     DOI: 10.1038/ajg.2014.132

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  45 in total

1.  Increasing Mortality Among Patients With Diabetes and Chronic Liver Disease From 2007 to 2017.

Authors:  Donghee Kim; George Cholankeril; Sun H Kim; Fahim Abbasi; Joshua W Knowles; Aijaz Ahmed
Journal:  Clin Gastroenterol Hepatol       Date:  2019-06-17       Impact factor: 11.382

2.  Response to Zoppini et al.

Authors:  Alice Fanin; Alberto Benetti; Ahmed Zakaria; Valerio Ceriani; Antonio E Pontiroli
Journal:  Am J Gastroenterol       Date:  2015-02       Impact factor: 10.864

3.  Effect of a Low Glycemic Index Mediterranean Diet on Non-Alcoholic Fatty Liver Disease. A Randomized Controlled Clinici Trial.

Authors:  G Misciagna; M Del Pilar Díaz; D V Caramia; C Bonfiglio; I Franco; M R Noviello; M Chiloiro; D I Abbrescia; A Mirizzi; M Tanzi; M G Caruso; M Correale; R Reddavide; R Inguaggiato; A M Cisternino; A R Osella
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

4.  XBP1s Is an Anti-lipogenic Protein.

Authors:  Hilde Herrema; Yingjiang Zhou; Dongyan Zhang; Justin Lee; Mario Andres Salazar Hernandez; Gerald I Shulman; Umut Ozcan
Journal:  J Biol Chem       Date:  2016-06-20       Impact factor: 5.157

Review 5.  Practical Dietary Recommendations for the Prevention and Management of Nonalcoholic Fatty Liver Disease in Adults.

Authors:  Elena S George; Adrienne Forsyth; Catherine Itsiopoulos; Amanda J Nicoll; Marno Ryan; Siddharth Sood; Stuart K Roberts; Audrey C Tierney
Journal:  Adv Nutr       Date:  2018-01-01       Impact factor: 8.701

6.  Is it time for non-alcoholic fatty liver disease screening in patients with type 2 diabetes mellitus?

Authors:  Giovanni Targher
Journal:  Hepatobiliary Surg Nutr       Date:  2020-04       Impact factor: 7.293

Review 7.  Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.

Authors:  Giovanni Targher; Amedeo Lonardo; Christopher D Byrne
Journal:  Nat Rev Endocrinol       Date:  2017-12-29       Impact factor: 43.330

Review 8.  Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.

Authors:  Vasilios G Athyros; Konstantinos Tziomalos; Niki Katsiki; Michael Doumas; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

9.  Association between diabetes mellitus and cirrhosis mortality: the Singapore Chinese Health Study.

Authors:  George Boon-Bee Goh; An Pan; Wan-Cheng Chow; Jian-Min Yuan; Woon-Puay Koh
Journal:  Liver Int       Date:  2016-09-16       Impact factor: 5.828

10.  Portal Hypertension Complications Are Frequently the First Presentation of NAFLD in Patients Undergoing Liver Transplantation Evaluation.

Authors:  Sajan Jiv Singh Nagpal; Mohammad Nasser Kabbany; Bashar Mohamad; Rocio Lopez; Nizar N Zein; Naim Alkhouri
Journal:  Dig Dis Sci       Date:  2016-03-18       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.